Clinical Trials Browser

Breast Neoplasms

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms, Neoplasms, Squamous Cell

Brain Neoplasms, Glioma, Neoplasms, Spinal Cord Neoplasms

Recurrence, Endometrial Neoplasms

Breast Neoplasms, Triple Negative Breast Neoplasms

Lymphoma, Non-Hodgkin, Multiple Myeloma, Neoplasms

Small Cell Lung Carcinoma

Pathologic Complete Response, Breast Neoplasms, Hemangiosarcoma, Neoplasms, Triple Negative Breast Neoplasms

Low Grade Serous Ovarian Carcinoma

Breast Neoplasms

Breast Neoplasms, Male

Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms

Liver Metastases From Colorectal Cancer (mCRC)

Anatomic Stage III Breast Cancer AJCC v8

Breast Neoplasms

Brain Neoplasms, Neoplasm Metastasis

Neoplasm Metastasis, Sarcoma, Ewing

Anatomic Stage IV Breast Cancer AJCC v8

Bulbo-Spinal Atrophy, X-Linked, Triple Negative Breast Neoplasms

Adenocarcinoma of Endometrium

Breast Neoplasms

Breast Neoplasms

Ovarian Neoplasms

Endometrial Neoplasms

Malignant Neoplasms of Female Genital Organs

Breast Neoplasms, Neoplasm, Residual

Breast Neoplasms

Clinical Trials

ABBY

Immune Modulation by Abemaciclib in Head and Neck Squamous Cell Carcinoma (HNSCC). (AIM Trial)

A Study Comparing Abemaciclib Plus Temozolomide to Temozolomide Monotherapy in Children and Young Adults With High-grade Glioma Following Radiotherapy

A Study of Elacestrant Alone or in Combination With Abemaciclib in People With Endometrial Cancer

EVOLVE-BDT

TAPUR

Targeted Therapy With CDK4/6 Inhibitors in Chemo-Refractory, Rb Wild-Type Extensive SCLC

Vismodegib, FAK Inhibitor GSK2256098, Capivasertib, and Abemaciclib in Treating Patients With Progressive Meningiomas

I-SPY

ALEPRO

Abemaciclib and Endocrine Therapy in Older Patients With Breast Cancer.

ETHAN - ET for Male BC

Study of the CDK4/6 Inhibitor Abemaciclib in Solid Tumors Harboring Genetic Alterations in Genes Encoding D-Type Cyclins or Amplification of CDK4 or CDK6

A Precision Medicine Approach (SMMART-ACT) for the Treatment of Patients With Advanced Sarcoma, Prostate, Breast, Ovarian or Pancreatic Cancer

Abemaciclib Combined With FOLFOX/FOLFIRI Regimen in Patients With Advanced Colorectal Liver Metastases Cancer

Functional Imaging in Prediction of Response to Abemaciclib for Advanced Hormone Receptor-Positive, HER2-Negative Breast Cancer

FAIM

Genetic Testing in Guiding Treatment for Patients With Brain Metastases

CAMPFIRE: A Study of Abemaciclib (LY2835219) in Participants With Ewing's Sarcoma

A Vaccine (STEMVAC) With Standard Endocrine-Based Therapy or Chemotherapy for the Treatment of Metastatic Hormone Receptor Positive, HER2 Negative Breast Cancer

ABBICAR

CAMPFIRE

Evaluating Cancer Response to Treatment With Abemaciclib and Fulvestrant in Women With Recurrent Endometrial Cancer

Abemaciclib in Newly Diagnosed Meningioma Patients

CARABELA

Anastrazole, Fulvestrant & Abemaciclib for HR+HER2- Metastatic Breast Cancer

BOUQUET

Abemaciclib and Letrozole to Treat Endometrial Cancer

Fulvestrant Plus Abemaciclib in Women With Advanced Low Grade Serous Carcinoma

MiRaDoR

VIOLET